WOCKPHARMA2020-07-012020-09-30in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:FourOperatingExpenses01Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:FourOperatingExpenses02Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2020-07-012020-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2020-04-01 2021-03-31 2020-10-23 INR Crores Half yearly true Cash Flow Indirect Single segment Pharmaceuticals 2020-07-01 2020-09-30 Unaudited Consolidated 7140500000.00 162400000.00 7302900000.00 2173200000.00 1273600000.00 -516900000.00 1973700000.00 609000000.00 571500000.00 2069900000.00 8154000000.00 -851100000.00 0.00 -851100000.00 -121700000.00 -762300000.00 -884000000.00 0.00 32900000.00 0.00 0.00 0.00 0.00 32900000.00 -45100000.00 -12200000.00 35500000.00 -2600000.00 -8900000.00 -3300000.00 553800000.00 5 0.32 0.32 0.00 0.00 0.32 0.32 Notes To consolidated Results:- n n1. For Notes to Consolidated Results please refer the notes from the Statement of Consolidated Unaudited Results for the quarter and six months ended September 30, 2020 as attached which is submitted under Outcome of Board Meeting. n n2. Income represents Income from continuing operations, Expenses represents Expenses from continuing operations, Exceptional items represents Exceptional items- (charge) from Continuing Operations, Tax expense represents Tax expense of continuing operations, Total profit before exceptional items and tax represents (Loss) before exceptional items and tax from Continuing Operations, Total profit before tax represents (Loss) after exceptional items and before tax from Continuing Operations and Profit / (Loss) from discontinued operations before tax represents Profit after exceptional items and before tax from Discontinued Operations. Net Profit / (Loss) from discontinued operations after tax represents Profit from Discontinued Operations.ttttttttttttttt n3. Profit / (Loss) from Discontinued Operations before tax for half year ended 30.09.2020 includes Profit before exceptional items and tax from Discontinued Operations Rs. 13.87 crore and Exceptional items- credit / (charge)- Discontinued Operations Rs. 1470.32 crore n n4. Tax expense represents Tax expense of continuing operations which includes Current tax - (credit) of Rs. (12.17) crore and Rs (78.29) crore for quarter ended 30.09.2020 and half year ended 30.09.2020 respectively; and Deferred tax- (credit) of Rs. (76.23) crore and Rs. (120.77) crore for quarter ended 30.09.2020 and half year ended 30.09.2020 respectively. n n5. Tax expense of discontinued operations for half year ended 30.09.2020 includes Current tax - charge of Rs. 311.49 crore and Deferred tax - charge of Rs. 187.37 crore n n6. Diluted EPS from continuing and discontinued operations for the half year ended September 30, 2020 is Rs.68.67 instead of Rs. 68.59 calculated as per table.t n n7. EPS for the Quarter and half year ended 09.30.2020 from Continuing operations, Discontinued operations and Continuing and Discontinued operations is not annualised. n nOCI Segment: n8. Income tax relating items that will not be classified to Profit or loss includes income tax relating to items that will not be reclassified to Profit or loss from Continuing operations and Discontinued operations. Single segment 2020-04-01 2020-09-30 Unaudited Consolidated 13123200000.00 241900000.00 13365100000.00 3343100000.00 2864300000.00 -1094600000.00 3998600000.00 1346000000.00 1131100000.00 4565300000.00 16153800000.00 -2788700000.00 -1424800000.00 -4213500000.00 -782900000.00 -1207700000.00 -1990600000.00 0.00 -2222900000.00 14841900000.00 4988600000.00 9853300000.00 0.00 7630400000.00 101100000.00 7731500000.00 7636100000.00 -5700000.00 7709600000.00 21900000.00 553800000.00 5 -20.02 -20.02 88.98 88.61 68.96 68.59 Exchange fluctuation loss / (gain), net 105900000.00 Other expenses 1964000000.00 Exchange fluctuation loss / (gain), net 192500000.00 Other expenses 4372800000.00 1346000000.00 -1549400000.00 2473900000.00 0.00 -644400000.00 0.00 0.00 0.00 0.00 -3363800000.00 0.00 0.00 0.00 1131300000.00 1890500000.00 0.00 0.00 0.00 0.00 245800000.00 0.00 164700000.00 12900000.00 0.00 0.00 0.00 138700000.00 32200000.00 0.00 1549000000.00 -2664500000.00 0.00 0.00 0.00 580200000.00 0.00 -3244700000.00 15345000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 762500000.00 35700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 98100000.00 0.00 -316900000.00 0.00 14399400000.00 0.00 0.00 100000.00 0.00 0.00 0.00 0.00 0.00 0.00 3825000000.00 0.00 320800000.00 0.00 758700000.00 0.00 0.00 -4904400000.00 6250300000.00 0.00 6250300000.00 2156600000.00 8406900000.00